The pioneering Yellow Card Biobank, a pilot launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, has begun investigating a new group of medicines used to prevent strokes known as Direct Oral Anticoagulants. The Yellow Card Biobank aims to help understand how a patient’s genetic makeup can impact the safety of their medicines and forms part of…
Ben KempFebruary 21, 2024